California Marijuana

ASHKELON, Israel, and VANCOUVER, BC — BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical cannabis in Israel. Recent regulatory reforms approved by the Israeli Ministry of Healthi allows physicians to prescribe cannabis to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical cannabis patientsii in the wake of recent events, particularly the opening of the war in Gaza. This surge has resulted in more than 2,000 new patients in just one month, approaching the peak numbers of 2021 and bringing the total number to over 132,000 as of November 2023. BYND Cannasoft’s proprietary Benefit CRM enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset manag...

A record 70 percent of US adults believe that “the use of marijuana should be legal,” according to nationwide polling data released today by Gallup. That’s an increase of 19 percentage points since 2014, when Colorado and Washington became the first states to implement adult-use cannabis legalization, and the highest level of support ever reported by Gallup pollsters. “There’s no ‘buyers remorse’ among the public when it comes to legalizing cannabis,” NORML’s Deputy Director Paul Armentano said. “As more states have adopted legalization, public support for this policy has risen dramatically. That’s because these policies are largely working as intended and because voters prefer legalization and regulation over the failed policy of marijuana prohibition.” Pollsters reported that Americans back legalization regardless of age and political party affiliation. “Majority support for legalization is found among all major subgroups, including by age, political party and ideology,” they d...

TALLAHASSEE, Fla.  — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the U.S., today announced it has issued a notice of redemption for all of its outstanding 9.75% senior secured notes due 2024 (CUSIP: 89788CAB0 / ISIN: CA89788CAB06) (the “Notes”). The aggregate principal amount of the Notes currently outstanding is US$130,000,000. As set forth in the notice of redemption, the redemption date will be December 1, 2023 (“the Redemption Date”), and the redemption price is 100% of the principal redeemed, plus accrued and unpaid interest up to, but excluding, the Redemption Date. The Notes trade on the Canadian Securities Exchange under the symbol “TRUL.DB.U”. In conjunction with the redemption, the Notes will be delisted from the Canadian Securities Exchange. On November 8, 2023, a copy of the notice of redemption was issued to record holders. Payment of the redemption price and surrender of the Notes for redemption will be as of D...

LOUISVILLE, Colo.  – BDSA, the leading provider of market intelligence for the cannabis industry, today announced the expansion of its Retail Sales Tracking and Menu Analytics products to include the Ohio medical cannabis market. This expansion comes as a response to the growing demand and dynamic growth of the Midwest cannabis markets, including Ohio, which experienced 26% sales growth in 2022 and is on track to reach $520 million in sales by the end of this year. Despite having only a few years of legal sales under its belt, the Ohio cannabis market has exhibited strong early growth that indicates continued expansion for the future. BDSA projects that Ohio will launch adult-use cannabis in 2025, contributing an estimated $300 million in that year alone. As a result, the total legal cannabis market in Ohio is anticipated to surge to $820 million in 2025 and an impressive $1.65 billion in 2027, establishing Ohio as one of the fastest-growing legal cannabis markets in the United St...

JERSEY, Channel Islands  — Ireland is set to get its first medicinal cannabis clinic, covering all therapy areas, since it became legalised in June 2019. Medicann, the award winning medicinal cannabis clinic is launching the first  clinic in Ireland, and are now accepting patients who wish to know if they are eligible for treatment with this natural medication. The new clinic covers all conditions treatable with medicinal cannabis, and not just those recognised by the Medical Cannabis Access Programme in Ireland. Through a virtual appointment, via our secure tele-health portal we can establish if you are eligible to be prescribed medicinal cannabis which comes in various forms flowers, oils and topical creams to help patients. With an experienced team of local specialist consultants, Medicann’s first clinic opened in 2019. Gary Whipp, CEO of Medicann Ireland said “When medicinal cannabis first became legalised in the UK back in 2018, early on I saw the potential it ha...

NEW YORK  – Ascend Wellness Holdings, Inc. (“AWH” or the “Company” or “Ascend”) (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis, today reported its financial results for the three months ending September 30, 2023 (“Q3 2023”). Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and all currency is in U.S. dollars. Q3 2023 Financial Highlights Gross revenue increased 26.6% year-over-year and 12.5% quarter-over-quarter to $169.9 million. Net revenue, which excludes intercompany sales of wholesale products, increased 27.0% year-over-year and 14.9% quarter-over-quarter to $141.3 million. Retail revenue increased 22.3% year-over-year and 12.7% quarter-over-quarter to $101.3 million. Gross wholesale revenue increased 33.4% year-over-year and 12.2% quarter-over-quarter to $68.7 million. Wholesale revenue, net of intercompany sales, increased 40.6% y...

TORONTO  – Trees Corporation (CBOE: TREE) announces, further to the Company’s press release dated July 13, 2023, that 420 Investments Ltd. (“420”) has unilaterally terminated the business combination agreement dated July 12, 2023, entered into between the Company and 420 (the “BCA”), effective as of November 2, 2023.The Company reserves all of its rights against 420 with regard to the unilateral termination by 420 of the BCA. The board of directors of the Company intends to undertake a comprehensive review to identify and consider a range of alternatives and their potential to enhance shareholder value. These alternatives could include, but are not limited to, a merger or business combination with another party, an asset sale, a strategic partnership or any combination of the foregoing.  The Company does not intend to set a definite schedule to complete its evaluation process and cautions that there are no assurances or guarantees that the process will result in a transaction,...